CoRISMA MCS Systems, Inc.
Biotechnology company · Hamden, Connecticut, United States
CoRISMA MCS Systems, Inc. is a biotechnology company headquartered in Hamden, Connecticut, United States. Its earliest recorded incorporation is in 2018. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $555,358 in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $5.2 million sold in a notice filed in 2021.
CoRISMA MCS Systems at a glance
What does CoRISMA MCS Systems do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $555,358 in total (2020). NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $5.2 million sold (2021).
Frequently asked questions about CoRISMA MCS Systems
Where is CoRISMA MCS Systems headquartered?
CoRISMA MCS Systems, Inc. is headquartered in Hamden, Connecticut, United States.
What does CoRISMA MCS Systems do?
CoRISMA MCS Systems, Inc. is a biotechnology company.
When was CoRISMA MCS Systems founded?
The earliest incorporation on record for CoRISMA MCS Systems, Inc. is in 2018, according to public company registers.
Similar companies
- Carogen CorporationHamden, Connecticut, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences